Wired has an updated article profiling the people involved in posting the Google doc based on the clinical study along with what other drugs are being tested.
Chloroquine May Fight Covid-19—and Silicon Valley’s Into Ithttps://www.wired.com/story/an-old-malaria-drug-may-fight-covid-19-and-silicon-valleys-into-it"Chloroquine and hydroxychloroquine aren’t the only candidates. There’s a protease inhibitor called camostat mesylate that a team of German scientists says works against the mechanism that SARS-CoV-2 uses to attach to the cells it infects. Virologists are pitching nucleoside analog inhibitors—remdesivir is one of these—that screw up the virus’ ability to replicate its RNA. Trials are actually going on—in China—on drugs like darunavir and cobicistat and interferon. And that doesn’t even get into the world of monoclonal antibodies that amp up a person’s own immune system to fight the virus."
"Physicians are already using chloroquine anyway, because there’s nothing else yet. President Donald Trump actually mentioned it in a press conference on Thursday, praising the fact that it’s already approved by the FDA, albeit, again, not specifically for Covid-19. “It’s show—encouraging, very, very encouraging early results,” Trump said. “And we’re going to be able to make that drug available almost immediately.”
"Not only is it already available, as it has been for almost a century, but Covid-19 patients are already getting it. Montefiore Medical Center in New York has already started seeing the surge of Covid-19 patients that public health experts have been warning about. The hospital is participating in the remdesivir trial and is giving Covid-19 patients chloroquine. “All of our patients get put on chloroquine, as well as on antiretrovirals. We’re using Kaletra. Different places are using different antiretrovirals,” says Liise-anne Pirofski, chief of infectious diseases at Albert Einstein College of Medicine and Montefiore. “Everybody gets that, unless they have some contraindication.”